Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6571065 | 0.82 | CA1 (0.38) | CA2TP53CA1TSHRGAA | |
| SCHEMBL1516383 | 0.76 | CA2 (0.50) | CA2TP53CA1TSHRGAA | |
| SCHEMBL1191549 | 0.71 | HTR7 (0.38) | CA2CA1LMNAHPGDKDM4E | |
| SCHEMBL49632 | 0.71 | TSHR (0.43) | CA2CA1TSHRLMNAHPGD | |
| SCHEMBL54888 | 0.71 | LMNA (0.47) | TP53TSHRLMNAMAPTHPGD | |
| SCHEMBL3232493 | 0.71 | FABP7 (0.35) | CA2CA1CA12CA4CA14 | |
| SCHEMBL97370 | 0.71 | CA1 (0.62) | CA2TP53CA1TSHRLMNA | |
| SCHEMBL95848 | 0.71 | PARP10 (0.39) | GAALMNAHPGDALDH1A1CYP3A4 | |
| SCHEMBL3815896 | 0.71 | ALDH1A1 (0.50) | CA2CA1TSHRGAALMNA | |
| SCHEMBL3835294 | 0.71 | KDM4E (0.55) | CA2CA1TSHRLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0004331-B1 | GLYCEROL PHOSPHITES ESTERIFIED WITH PHENOLCARBOXYLIC ACIDS, THEIR PREPARATION AND USE AS STABILIZERS FOR SYNTHETIC MATERIALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-05-13 | — | — | EP | claimed |
| US-10358567-B2 | Compound, ink, ink cartridge and ink jet recording method | CANON KABUSHIKI KAISHA (JP) | 2019-07-23 | — | — | US | disclosed |
| US-20170247557-A1 | COMPOUND, INK, INK CARTRIDGE AND INK JET RECORDING METHOD | CANON KABUSHIKI KAISHA (JP) | 2017-08-31 | — | — | US | disclosed |
| WO-2000049080-A1 | PHOTO CURABLE LIQUID RESIN COMPOSITION AND PHOTOFABRICATED CURED PRODUCT | DSM N.V. (NL) | 2000-08-24 | — | — | WO | disclosed |
| EP-0543662-B1 | Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses | SANKYO CO (JP) | 1996-09-18 | — | — | EP | disclosed |
| EP-0543662-A2 | Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 1993-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10358567-B2 | Compound, ink, ink cartridge and ink jet recording method | JAK1, JAK2, ETV6 | CA2 1196/4885TP53 1986/4885CA1 603/4885 |
| US-20170247557-A1 | COMPOUND, INK, INK CARTRIDGE AND INK JET RECORDING METHOD | JAK1, JAK2, ETV6 | CA2 1196/4885TP53 1986/4885CA1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.